|
Reference #:
1997-035
Inventors/Contributors
Robert T. Abraham, Ph.D., Brandi L. Williams
Description
This technology is a T-cell line that lacks the protein tyrosine kinase, ZAP-70. ZAP-70 plays a critical role in the initiation of lymphocyte activation responses to antigenic stimuli. The cell line can be used to define the mechanisms of ZAP-70 activation and function in T-cell signaling. This line can be used also to confirm the mechanism of action of ZAP-70 targeted drugs. This is the first genetically manipulatable T-cell model system that lacks the critical protein tyrosine kinase, ZAP-70.
Patent Status
None |
|
Contact
Julie A. Henry, Licensing Manager
henry.julie@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 266-4585
Fax: (507) 284-5410
|
|
|